Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
Pharma Stocks Rise Amid Weak Market; MTAR Technologies Declines for Third Day

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

Pharma Stocks Rise Amid Weak Market; MTAR Technologies Declines for Third Day

Analysed 20 Jul 2026·3 sources analysed·India·Business
Pharma Stocks Rise Amid Weak Market; MTAR Technologies Declines for Third DayPreviousNext

Pharma stocks rallied notably on Monday, with the Nifty Pharma index rising around 2% amid a weak broader market. Leading gainers included Torrent Pharmaceuticals, Mankind Pharma, Cipla, and Aurobindo Pharma, with some shares increasing up to 20%. Emcure Pharma received a 'Buy' rating from Motilal Oswal, citing strong growth prospects. Conversely, MTAR Technologies faced a third consecutive day of 5% declines, down 34% from its June high, amid trading restrictions and reduced domestic mutual fund holdings despite increased foreign investor interest.

Sentiment
61%
TBN's observations

First-hand measurement across 3 sources

We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (61/100). Lens Score 50/100.

Outlets measured: businessstandard, businessstandard, mint. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 3 sources · Published under editorial oversight by The Balanced News
Analysed 20 Jul 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Positive (61/100)

Sentiment was consistent across outlets (52–75/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

mint broke this story on 20 Jul, 07:08 am. Other outlets followed.

20 Jul, 07:08 am3 sources · 2 h20 Jul, 09:15 am
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
Raghu Vamsi Aerospace Group Raises $40 Million to Expand Manufacturing
Next →
Uttar Pradesh Advances Purvanchal Development with Infrastructure and Investment Push
  1. 1
    mint20 Jul, 07:08 am
    Cipla, Ajanta Pharma to Alkem Laboratories: Pharma stocks rise amid weak trends on Dalal Street Stock Market News
  2. 2
    businessstandard20 Jul, 07:56 am
    MTAR Technologies hits 3rd straight 5 lower limit; down 34 from June high
  3. 3
    businessstandard20 Jul, 09:15 am
    Pharma index surges 2 ; Torrent, Mankind, Cipla, Aurobindo soar up to 5

Who's involved

Institutions and figures named across source coverage.

Corporate
Mankind PharmaNeuland LaboratoriesIOL Chemicals PharmaceuticalsEmcure PharmaceuticalsSuven Life SciencesCiplaDivi's LaboratoriesRubicon ResearchRPG Life SciencesBNP Paribas IndiaThyrocare TechnologiesOnesource Specialty PharmaAjanta PharmaWockhardtDr Reddy's LaboratoriesAurobindo PharmaThemis MedicareZydus LifesciencesDivis LaboratoriesTatva Chintan Pharma ChemBloom Energy CorporationHester BiosciencesTorrent PharmaceuticalsLupinSai Life SciencesMTAR TechnologiesAlkem LaboratoriesMotilal Oswal Financial ServicesLaurus Labs

Story context

Category
Business
Location
India
Sources analysed
3
Last analysed
20 Jul 2026
Key entities
CiplaNational Stock Exchange of IndiaAurobindo PharmaCroreIndian rupeeRPG Life SciencesLaurus LabsHester BiosciencesAlkem LaboratoriesMankind PharmaThyrocareTorrent Pharmaceuticals